卡他莫拉菌的β-内酰胺酶及其被克拉维酸的抑制作用
beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.
作者信息
Farmer T, Reading C
出版信息
Antimicrob Agents Chemother. 1982 Mar;21(3):506-8. doi: 10.1128/AAC.21.3.506.
Abstract
Three of four clinical isolates of Branhamella catarrhalis from Belgium produced a beta-lactamase identical to enzymes previously reported to occur in French and British isolates of this organism. One strain, however, produced a new type of beta-lactamase. Both beta-lactamase types were readily inhibited by low concentrations of clavulanic acid.
摘要
从比利时分离出的4株卡他布兰汉菌临床菌株中，有3株产生的β-内酰胺酶与先前报道的法国和英国该菌分离株中出现的酶相同。然而，有1株产生了一种新型的β-内酰胺酶。两种β-内酰胺酶类型均易被低浓度的克拉维酸抑制。
相似文献
1
beta-Lactamases of Branhamella catarrhalis and their inhibition by clavulanic acid.卡他莫拉菌的β-内酰胺酶及其被克拉维酸的抑制作用
Antimicrob Agents Chemother. 1982 Mar;21(3):506-8. doi: 10.1128/AAC.21.3.506.
2
Branhamella catarrhalis: antibiotic sensitivities and beta-lactamases.卡他布兰汉菌：抗生素敏感性与β-内酰胺酶
J Antimicrob Chemother. 1984 Jan;13(1):55-64. doi: 10.1093/jac/13.1.55.
3
Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases.卡他布兰汉菌β-内酰胺酶的检测、分布及抑制作用
Drugs. 1986;31 Suppl 3:64-9. doi: 10.2165/00003495-198600313-00014.
4
Increased beta-lactamase activity in Branhamella catarrhalis after exposure to amoxicillin and clavulanic acid.
J Chemother. 1994 Dec;6(6):383-7. doi: 10.1080/1120009x.1994.11736493.
5
The origin and properties of beta-lactamase satellite bands seen in isoelectric focusing.在等电聚焦中观察到的β-内酰胺酶卫星条带的起源和特性。
J Antimicrob Chemother. 1983 Aug;12(2):127-31. doi: 10.1093/jac/12.2.127.
6
[beta-Lactamases of Branhamella catarrhalis and their phenotypic implications].[卡他莫拉菌的β-内酰胺酶及其表型意义]
Res Microbiol. 1995 Nov-Dec;146(9):761-71. doi: 10.1016/0923-2508(96)81072-2.
7
Role of Bacteroides bivius beta-lactamase in beta-lactam susceptibility.二路拟杆菌β-内酰胺酶在β-内酰胺敏感性中的作用。
Antimicrob Agents Chemother. 1984 Nov;26(5):694-8. doi: 10.1128/AAC.26.5.694.
8
In vitro activity of BRL 17421 against Haemophilus influenzae, Neisseria gonorrhoeae, and Branhamella catarrhalis.BRL 17421对流感嗜血杆菌、淋病奈瑟菌和卡他布兰汉菌的体外活性。
Antimicrob Agents Chemother. 1982 Jan;21(1):166-7. doi: 10.1128/AAC.21.1.166.
9
Contribution of beta-lactamases to bacterial resistance and mechanisms to inhibit beta-lactamases.β-内酰胺酶对细菌耐药性的作用以及抑制β-内酰胺酶的机制。
Am J Med. 1985 Nov 29;79(5B):2-12. doi: 10.1016/0002-9343(85)90123-8.
10
In-vitro evaluation of the four beta-lactamase inhibitors: BRL42715, clavulanic acid, sulbactam, and tazobactam.四种β-内酰胺酶抑制剂：BRL42715、克拉维酸、舒巴坦和他唑巴坦的体外评估。
J Antimicrob Chemother. 1993 Sep;32(3):421-9. doi: 10.1093/jac/32.3.421.
引用本文的文献
1
Antimicrobial resistance in Haemophilus influenzae and Moraxella catarrhalis respiratory tract isolates: results of the Canadian Respiratory Organism Susceptibility Study, 1997 to 2002.流感嗜血杆菌和卡他莫拉菌呼吸道分离株中的抗菌药物耐药性：1997年至2002年加拿大呼吸道病原体敏感性研究结果
Antimicrob Agents Chemother. 2003 Jun;47(6):1875-81. doi: 10.1128/AAC.47.6.1875-1881.2003.
2
Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.对1994 - 1995年及1997 - 1998年期间从美国24个医疗中心获取的卡他莫拉菌（布兰汉菌）临床分离株中的β-内酰胺酶进行分子特征分析。
Antimicrob Agents Chemother. 2000 Feb;44(2):444-6. doi: 10.1128/AAC.44.2.444-446.2000.
3
Interaction of Streptococcus pneumoniae and Moraxella catarrhalis: investigation of the indirect pathogenic role of beta-lactamase-producing moraxellae by use of a continuous-culture biofilm system.肺炎链球菌与卡他莫拉菌的相互作用：利用连续培养生物膜系统研究产β-内酰胺酶卡他莫拉菌的间接致病作用。
Antimicrob Agents Chemother. 1998 Oct;42(10):2521-6. doi: 10.1128/AAC.42.10.2521.
4
Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.卡他莫拉菌：临床意义、抗菌药物敏感性及 BRO β-内酰胺酶
Eur J Clin Microbiol Infect Dis. 1998 Apr;17(4):219-34. doi: 10.1007/BF01699978.
5
[Moraxella catarrhalis: virulence and resistance mechanisms].[卡他莫拉菌：毒力与耐药机制]
Med Klin (Munich). 1997 Mar 15;92(3):162-6. doi: 10.1007/BF03043274.
6
Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study.1994年和1995年美国723株卡他莫拉菌门诊临床分离株的抗菌药物耐药性流行情况：一项30中心全国性监测研究的结果
Antimicrob Agents Chemother. 1996 Dec;40(12):2884-6. doi: 10.1128/AAC.40.12.2884.
7
Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.卡他莫拉菌（布兰汉菌属）BROβ-内酰胺酶的分子特征
Antimicrob Agents Chemother. 1996 Apr;40(4):966-72. doi: 10.1128/AAC.40.4.966.
8
A functional classification scheme for beta-lactamases and its correlation with molecular structure.β-内酰胺酶的功能分类方案及其与分子结构的相关性。
Antimicrob Agents Chemother. 1995 Jun;39(6):1211-33. doi: 10.1128/AAC.39.6.1211.
9
Efficacy of BRL 25000 against Serratia marcescens, Enterobacter cloacae, and Citrobacter freundii in urinary tract infections.BRL 25000对尿路感染中的粘质沙雷氏菌、阴沟肠杆菌和弗氏柠檬酸杆菌的疗效。
Antimicrob Agents Chemother. 1983 Sep;24(3):437-9. doi: 10.1128/AAC.24.3.437.
10
Multiresistance plasmid from commensal Neisseria strains.共生奈瑟菌菌株的多抗性质粒
Antimicrob Agents Chemother. 1985 Jan;27(1):120-4. doi: 10.1128/AAC.27.1.120.
本文引用的文献
1
Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.1978 - 1979年英国铜绿假单胞菌对羧苄青霉素和替卡西林的敏感性及β-内酰胺酶研究
J Clin Pathol. 1980 Mar;33(3):297-301. doi: 10.1136/jcp.33.3.297.
2
Inhibition of the -lactamases of Escherichia coli and Klebsiella aerogenes by semi-synthetic penicillins.半合成青霉素对大肠杆菌和产气克雷伯菌β-内酰胺酶的抑制作用。
Biochem J. 1972 Mar;127(1):295-308. doi: 10.1042/bj1270295.
3
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate.一种使用显色头孢菌素底物检测β-内酰胺酶的新方法。
Antimicrob Agents Chemother. 1972 Apr;1(4):283-8. doi: 10.1128/AAC.1.4.283.
4
Clavulanic acid: a beta-lactamase-inhiting beta-lactam from Streptomyces clavuligerus.克拉维酸：一种来自棒状链霉菌的β-内酰胺酶抑制性β-内酰胺类抗生素。
Antimicrob Agents Chemother. 1977 May;11(5):852-7. doi: 10.1128/AAC.11.5.852.
5
Fatal Neisseria (Branhamella) catarrhalis pneumonia in an immunodeficient host.免疫缺陷宿主中的致死性卡他莫拉菌（布兰汉菌属）肺炎
Am Rev Respir Dis. 1976 Aug;114(2):399-402. doi: 10.1164/arrd.1976.114.2.399.
6
Bronchopulmonary infection due to Branhamella catarrhalis: 11 cases assessed by transtracheal puncture.卡他布兰汉菌引起的支气管肺部感染：经气管穿刺评估的11例病例
Br Med J. 1978 Feb 4;1(6108):276-8. doi: 10.1136/bmj.1.6108.276.
7
In vitro sensitivity to penicillin V and beta-lactamase production of Branhamella catarrhalis.卡他布兰汉菌对青霉素V的体外敏感性及β-内酰胺酶的产生
J Antimicrob Chemother. 1977 Jul;3(4):374-5. doi: 10.1093/jac/3.4.374.
8
Novel beta-lactamase from Branhamella catarrhalis.来自卡他莫拉菌的新型β-内酰胺酶。
Ann Microbiol (Paris). 1978 Oct;129 B(3):397-406.
9
Bronchopulmonary infection due to beta-lactamase-producing Branhamella catarrhalis treated with amoxycillin/clavulanic-acid.产β-内酰胺酶的卡他布兰汉菌引起的支气管肺部感染，用阿莫西林/克拉维酸治疗。
Lancet. 1978 Jul 29;2(8083):257. doi: 10.1016/s0140-6736(78)91763-4.
10
Pathogenicity of and beta-lactamase production by Branhamella (Neisseria) catarrhalis.卡他布兰汉菌（奈瑟菌属）的致病性及β-内酰胺酶产生情况
Lancet. 1977 Dec 3;2(8049):1175. doi: 10.1016/s0140-6736(77)91562-8.
Zotero 插件